Previous work suggests that SOD3 functions as a protective mechanism against NAFLD development by inhibiting the expression of inflammatory genes in adipose tissue,72 which aligns with our hypothesis that NAFLD onset is triggered by dysfunctional and inflamed adipose tissue. The gene discussed is SOD3; the disease is metabolic dysfunction-associated steatotic liver disease.